Document is current
Any future updates will be listed below
-
Authors
Johnston, Karissa M. https://orcid.org/0000-0003-4570-9972
L’Italien, Gilbert
Popoff, Evan
Powell, Lauren
Croop, Robert
Thiry, Alexandra
Harris, Linda
Coric, Vladimir
Lipton, Richard B.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03266588 at ClinicalTrials.govDocuments that mention this clinical trial
Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
https://doi.org/10.1007/s40122-024-00675-6
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
https://doi.org/10.1007/s40122-024-00626-1
Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant
https://doi.org/10.1007/s12325-021-01897-2
159 Long-term safety and discontinuation for rimegepant versus triptans: a matching-adjusted indirect comparison
https://doi.org/10.1136/jnnp-2025-abn.159
-
Funding
Funding for this research was provided by:
biohaven pharmaceuticals inc.
- License Information
-
More Information
Article History
Received: 15 July 2021
Accepted: 18 August 2021
First Online: 29 August 2021
